NVSEF News and Press, Novartis AG Registered Shares

2026-07-08 14:46:06 ET Shares of pure-play cell therapy concern Legend Biotech Corporation ( LEGN ) recently jumped 42% on news that its early-stage CAR-T cell candidate LB2501 showed promise against non-Hodgkin lymphoma. This somewhat stemmed a seven-month, 64% decline (July 20...

2026-07-04 08:00:00 ET The last time I spoke about Novartis ( NVS ) it was with a Seeking Alpha article entitled " Novartis: Synnovation Deal And 8% Full-Year 2025 Sales Growth ." With respect to this article, I mentioned that the company had achieved full-year 2025 sales gr...

2026-07-02 14:20:44 ET More on Novartis Novartis Plays Long Game With Antares Deal - Meaning Near-Term Upside Unlikely Novartis: H2 Pipeline Readouts Matter, But Valuation Leaves Limited Upside Novartis AG (NVS) Q1 2026 Earnings Call Transcript Novartis and A...

2026-06-30 09:03:16 ET Thesis and Something of a Personal Disclaimer I have been covering Vertex Pharmaceuticals Incorporated ( VRTX ) for over 18 months as a Seeking Alpha analyst and been an investor since 2020. Moreover, as someone with cystic fibrosis ((CF)), I have ...

2026-06-25 11:33:44 ET Investment Overview The privately held biotech Antares Therapeutics announced yesterday that it had struck a deal with Swiss Pharma giant Novartis AG ( NVS ): to discover, develop and commercialize small molecule therapies against promising b...

2026-06-25 09:36:18 ET So, since my March article "GSK Expanding Fast - Oncology, HIV, And Smart Acquisitions" , GSK's stock price tested the +3σ band formed from the VWAP, $58.80, but then corrected back to $51.10.... Read the full article on Seeking Alpha For furthe...

2026-06-24 22:05:00 ET The following segment was excerpted from the TCW Relative Value Large Cap Fund Q1 2026 Commentary. ... Read the full article on Seeking Alpha For further details see: TCW Relative Value Large Cap Fund Q1 2026 Buys A...

2026-06-24 10:06:26 ET More on Novartis Novartis: H2 Pipeline Readouts Matter, But Valuation Leaves Limited Upside Novartis AG (NVS) Q1 2026 Earnings Call Transcript Novartis: Revenue Lags In Q1, Outlook Unchanged Novartis muscle disease therapy succeeds in e...

2026-06-24 09:08:33 ET Since my February article , " Vertex Pharmaceuticals Stock: Is The Bull Run Over, " Vertex Pharmaceuticals Incorporated ( VRTX ) shares have declined by as much as 12%, hitting a low of $412.9 on May 5, before rallying to the +1σ band formed fro...

2026-06-23 12:55:55 ET So, since my October comparison article , " Teva Vs. Viatris: Who Will Dominate In President Trump's America? ," Viatris Inc.'s ( VTRS ) shares have risen 54.1%, outperforming Sandoz Group [45.3% return] ( SDZNY ), its key competitor in the generic...